HOME >> MEDICINE >> NEWS
Low Socio-Economic Status Heart Patients Need More Than Just Aggressive Cardiac Procedures

DALLAS -- While aggressive procedures such as angioplasty and coronary bypass procedures improve the health of patients with heart disease, the benefits are less if patients don't have the financial means to protect that "investment" afterwards.

In a study of 800 patients, Duke University Medical Center researchers have found that heart patients of low socio-economic status (SES) have a worse quality of life after these aggressive forms of treatment than better-off and more educated patients.

"If patients don't understand what healthy living is or don't have the means to live healthier, they will not do as well, " said Duke cardiologist Dr. Chen Tung.

The issues facing this group of patients after treatment are complicated and not easily solved, Tung said. Most need to drastically change their lifestyles, may need physical rehabilitation, and need to take heart medications -- aspects of continuing medical care that can be either out of reach or not fully understood by most low SES patients.

Tung, who is on the faculty at the Duke Clinical Research Institute, prepared the results of his study for presentation Tuesday (Nov. 10) at the 71st scientific sessions of the American Heart Association meeting.

The study followed 800 consecutive patients who were referred to Duke for a cardiac catheterization and who then went on to receive either an angioplasty or bypass. Of these patients, 350 were of low SES, which was defined as having less than nine years of education and an annual income of less than $10,000. These patients tended to be older than high SES patients and a higher percentage were women.

The study found that patients from low SES came to the hospital sicker than high SES patients, and while both groups experienced small but marked improvements after either revascularization procedure, the functional status of lower SES patients remained significantly impaired one year af
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
10-Nov-1998


Page: 1 2

Related medicine news :

1. Recording Patients Socio-Economic Status Is Necessary For Tackling Health Inequalities
2. Status syndrome: How your social standing directly affects your health and life expectancy
3. Socioeconomic Status Linked To Enlarged Hearts, Heart Disease Risk
4. Lewin Study Confirms Diabetes Treatment Centers of Americas Diabetes NetCareSM Program Improves Health Status, Reduces Medical Costs
5. The European Society of Cardiology launches Women at Heart
6. Heart surgeons publish death rates
7. Heart attack treatment gap may be closing for women
8. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
9. Brenner Childrens Hospital named to NIH Pediatric Heart Network
10. Heart patients treated by non-cardiologists less likely to receive medications
11. Heart failure patients treated for diabetes with insulin have increase in mortality

Post Your Comments:
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... According to ... been developed that changes color when subjected to an impact force that is great ... be implemented in helmets or other sporting equipment so that coaches or officials would ...
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article published August ... Association presented data showing that it is safe for pregnant women to undergo local ... had undergone local anesthesia with a group that hadn’t, researchers were able to determine ...
(Date:9/4/2015)... ... September 04, 2015 , ... On ... has effectively doubled the size of its annual health tech innovation program. Now ... digital health startups to compete for cash and prizes to advance their technologies ...
(Date:9/4/2015)... , ... September 04, 2015 , ... With TransCel from ... mouse all within Final Cut Pro X. With TransCel users have full control over ... width, background color, speed method, frame color, inner color, text, and more. With TransCel ...
(Date:9/4/2015)... ... 2015 , ... Mile High Connects today releases “First and Last Mile Connections,” ... sidewalks, bike paths, and other vital supports severely limit access to public transportation for ... dollars to expand public transit, there’s very little support for safe and convenient access ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Missed Connections in Metro Denver Transit 2
(Date:9/4/2015)... , Sept. 4, 2015  Janssen Research & ... and Drug Administration (FDA) has accepted for Priority ... as a treatment for patients with multiple myeloma ... (PI) and an immunomodulatory agent (IMiD), or who ... therapy, including a PI and an IMiD. This ...
(Date:9/4/2015)... -- Fair Rate Funding, a lawsuit funding firm located in ... increase in lawsuit filings in connection with the blood thinning ... Philadelphia Court of Common Pleas has ... Louisiana multi---district litigation (MDL), located in ... Louisiana , the filings are also on the ...
(Date:9/4/2015)... HILL, N.C. , Sept. 4, 2015 /PRNewswire/ ... Liaisons (MSLs) and other Field-Based Medical Specialists (FBMS) ... key opinion leaders, and thought leaders in critical ... effectiveness of their field-based teams, companies are expanding ... order to align countries with corporate objectives and ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2
Cached News: